Phase I trial of AEZS 108 in women with LHRH-positive breast, ovarian or endometrial cancer.
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2007
At a glance
- Drugs Zoptarelin doxorubicin (Primary)
- Indications Breast cancer; Endometrial cancer; Ovarian cancer
- Focus Adverse reactions
- 21 Jun 2007 New trial record.